查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837116

轉染試劑和設備市場（按產品類型、細胞類型、應用和最終用戶分類）—2025-2032 年全球預測

Transfection Reagents & Equipment Market by Product Type, Cell Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，轉染試劑和設備市場將成長至 75.1 億美元，複合年成長率為 13.15%。

主要市場統計數據
基準年2024年 27.9億美元
預計2025年 31.5億美元
預測年份：2032年 75.1億美元
複合年成長率（%） 13.15%

轉染試劑和設備正經歷快速的技術和商業性變革，這得益於遞送化學、自動化以及基因操作研究範圍的不斷擴大。過去幾年，研究人員和採購團隊已將採購重點從成本驅動轉向可重複性、擴充性和法規可追溯性。因此，供應商正在大力投資平台的穩健性、檢驗的方案以及整合的硬體和軟體解決方案，以減少不同細胞類型和實驗形式的差異。

本引言重點在於報告的主題：創新、營運韌性和最終用戶需求。它也強調了產品開發週期如何日益受到分子生物學家、工程師和生物資訊學家之間跨學科合作的影響。它還認知到生物製藥公司對支持加速轉化工作流程（包括細胞株開發和基因治療研究）的試劑和設備的日益成長的期望。透過將這些趨勢置於更廣泛的研究重點和採購慣例實踐背景中，引言確立了貫穿報告始終的分析視角，並預示著可操作的洞察將為策略決策提供支援。

變革性轉變重新定義了轉染工作流程，包括自動化、非病毒遞送創新、單細胞方法以及與基因編輯平台的整合

轉染生態系統正在經歷一場變革性的轉變，重塑從實驗室到臨床的工作流程。首先，轉染工作流程的自動化和微型化正在減少人工操作的差異性，並實現更高通量的實驗。其次，非病毒遞送創新，包括新一代脂質體、聚合物和物理方法，正在擴展可處理的細胞類型和有效載荷的範圍，使先前受毒性或低效率限制的應用成為可能。

同時，CRISPR-Cas系統等基因編輯平台的廣泛應用使得遞送試劑和編輯套件包能夠緊密整合，從而形成捆綁解決方案，從而提高編輯效率並減少脫靶效應。單細胞分析和高內涵篩檢也影響試劑配方和儀器設計，需要更溫和的遞送方法和更可重複的條件。此外，監管和品質預期推動了對具有完善文件記錄、批次間一致性以及與GMP工作流程相容的試劑和儀器的需求。這些共同的轉變迫使供應商和最終用戶重新思考其產品藍圖、驗證策略和服務模式，以保持競爭力並加速轉換效應。

評估 2025 年生效的美國關稅對生命科學實驗室的供應鏈、籌資策略和營運彈性的累積影響

2025年關稅帶來了一系列營運和策略壓力，影響了整個轉染價值鏈的採購、供應商關係和成本結構。緊接著，許多實驗室和組織重新評估了籌資策略，以緩解短期成本上漲，優先選擇製造地分散或能夠提供區域庫存緩衝的供應商。這些調整通常包括重新協商條款和條件、整合訂單以支援價格，以及與經銷商密切合作以維持供應的連續性。

從長遠來看，關稅加速了關鍵生產回流和供應商裁員的討論。那些擁有靈活營運能力，能夠適應生產重新分配和零件採購變化的公司，在保障實驗連續性方面處於有利地位。同時，規模較小的學術和研究機構面臨更嚴峻的預算壓力，促使採購團隊尋求能夠在整個計劃中提供更廣泛效用的多用途試劑和設備。重要的是，關稅上調提升了供應鏈透明度和供應商風險評估的策略重要性，鼓勵各組織投資於供應商資格認證和庫存規劃，以便在不斷變化的貿易條件下維持其開發平臺。

跨產品類型、電池類型、應用程式和最終用戶的關鍵細分洞察揭示了細微的需求促進因素和採購行為

它揭示了不同產品類型、細胞類型、應用和最終用戶的需求模式和營運要求。根據產品類型，市場分為儀器和試劑兩類，設備採購越來越受到與自動化系統的兼容性和數據整合的影響，而試劑的評估則基於配方穩定性和跨平台性能。根據細胞類型，市場涵蓋細菌、昆蟲、哺乳動物和植物細胞，每個類別都專注於轉染靈敏度、通量需求以及影響試劑選擇和方案開發的驗證挑戰。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 在 mRNA 疫苗遞送和基因編輯應用中採用脂質奈米顆粒製劑
  • 整合自動化高通量轉染平台，用於大規模篩檢和研究
  • 開發非病毒載體最佳化策略以提高基因治療的安全性和遞送效率
  • 電轉染裝置小型化進展，可實現精確的細胞內遞送，同時減少細胞損傷
  • 實施人工智慧輔助試劑混合最佳化可提高轉染效率和可重複性。
  • 符合 GMP 標準的轉染工作流程的興起，支持細胞和基因治療的臨床生產
  • 建構基於胜肽的遞送系統，用於治療性貨物分子的細胞內標靶運輸
  • 擴展雙重遞送平台，實現 DNA 和 RNA 的共轉染，實現複雜的細胞調控
  • 試劑製造中永續製造流程和綠色化學的出現，以減少對環境的影響
  • 採用基於微流體的轉染裝置進行單細胞分析和精確基因傳遞

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 轉染試劑和設備市場（依產品類型）

  • 裝置
  • 試劑

9. 轉染試劑和設備市場（依細胞類型）

  • 細菌細胞
  • 昆蟲細胞
  • 哺乳動物細胞
  • 植物細胞

第 10 章：轉染試劑與設備市場（依應用）

  • 細胞株開發
  • 藥物研發
  • 基因治療研究

第 11 章：轉染試劑和設備市場（依最終用戶）

  • 學術研究機構
  • 生物製藥公司
  • 合約研究組織

第 12 章：轉染試劑和設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章：轉染試劑和設備市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。按國家/地區分類的轉染試劑和設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Agilent Technologies, Inc.
    • Altogen Biosystems
    • Applied Biological Materials, Inc.
    • Bex Co.,ltd.
    • BioVision Inc.
    • Bio-Rad Laboratories, Inc.
    • Cytiva
    • GeneCopoeia, Inc.
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
Product Code: MRR-031685195779

The Transfection Reagents & Equipment Market is projected to grow by USD 7.51 billion at a CAGR of 13.15% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.79 billion
Estimated Year [2025] USD 3.15 billion
Forecast Year [2032] USD 7.51 billion
CAGR (%) 13.15%

The transfection reagents and equipment landscape is experiencing rapid technological and commercial evolution, driven by converging advances in delivery chemistry, automation, and the expanding scope of gene-modulation research. Over the past several years, researchers and procurement teams have shifted priorities from cost-centric purchasing to an emphasis on reproducibility, scalability, and regulatory traceability. As a result, suppliers are investing heavily in platform robustness, validated protocols, and integrated hardware-software solutions that reduce variability across cell types and experimental formats.

This introduction frames the report's thematic focus on innovation, operational resilience, and end-user needs. It highlights how product development cycles are increasingly informed by cross-disciplinary collaboration between molecular biologists, engineers, and bioinformaticians. In addition, it acknowledges the heightened expectations from biopharmaceutical companies for reagents and instruments that support accelerated translational workflows, including cell line development and gene therapy research. By situating these trends within the broader context of research priorities and procurement practices, the introduction establishes the analytic lens used throughout the report and sets expectations for actionable insights that support strategic decision-making.

Transformative shifts redefining transfection workflows including automation, non-viral delivery innovations, single-cell approaches, and convergence with gene editing platforms

The transfection ecosystem is undergoing transformative shifts that are reshaping workflows from bench to clinic. First, automation and miniaturization of transfection workflows have reduced manual variability and enabled higher-throughput experimentation, which supports more rapid iterative cycles in protocol optimization. Second, non-viral delivery innovations, including next-generation lipids, polymers, and physical methods, are broadening the range of tractable cell types and payloads, enabling applications that were previously constrained by toxicity or low efficiency.

Concurrently, the widespread adoption of gene editing platforms such as CRISPR-Cas systems has created tighter integration between delivery reagents and editing toolkits, leading to bundled solutions that improve editing efficiency and reduce off-target effects. Single-cell analysis and high-content screening are also influencing reagent formulation and instrument design, requiring gentler delivery approaches and highly reproducible conditions. Moreover, regulatory and quality expectations are driving demand for reagents and equipment with robust documentation, lot-to-lot consistency, and compatibility with GMP workflows. Together, these shifts compel suppliers and end users to rethink product road maps, validation strategies, and service models to remain competitive and to accelerate translational impact.

Cumulative impact assessment of United States tariffs introduced in 2025 on supply chains, procurement strategies, and operational resilience across life science labs

The imposition of tariffs in 2025 introduced a set of operational and strategic pressures that have affected procurement, supplier relationships, and cost structures across the transfection value chain. In the immediate aftermath, many laboratories and organizations revisited sourcing strategies to mitigate near-term cost increases, prioritizing suppliers with diversified manufacturing footprints or those able to offer localized inventory buffers. These adjustments often involved renegotiating terms, consolidating orders to preserve pricing, and working more closely with distributors to maintain continuity of supply.

Over a longer horizon, tariffs have accelerated conversations about onshoring critical production and increasing supplier redundancy. Firms with the operational agility to reallocate production or to shift component sourcing have been better positioned to protect experimental continuity. At the same time, smaller academic and research institutions have faced more acute budgetary pressure, prompting procurement teams to seek multi-use reagents and instrumentation that deliver broader utility across projects. Importantly, tariffs have magnified the strategic importance of supply chain transparency and supplier risk assessment, encouraging organizations to invest in vendor qualification and inventory planning to sustain R&D pipelines under evolving trade conditions.

Key segmentation insights across product types, cell types, applications, and end users revealing nuanced demand drivers and procurement behaviors

Segmentation-driven insights reveal differentiated demand patterns and operational requirements across product types, cell types, applications, and end users. Based on Product Type, the market is studied across Equipment and Reagents, with equipment purchases increasingly influenced by compatibility with automation systems and data integration, while reagents are evaluated for formulation stability and cross-platform performance. Based on Cell Type, the market is studied across Bacterial Cells, Insect Cells, Mammalian Cells, and Plant Cells, and each category exhibits distinct transfection sensitivities, throughput needs, and validation challenges that influence reagent selection and protocol development.

Based on Application, the market is studied across Cell Line Development, Drug Discovery, and Gene Therapy Research, with cell line development demanding reproducibility and scale-up pathways, drug discovery emphasizing throughput and assay compatibility, and gene therapy research prioritizing delivery efficiency and regulatory-grade documentation. Based on End User, the market is studied across Academic And Research Institutes, Biopharmaceutical Companies, and Contract Research Organizations, where academic labs often prioritize flexibility and cost-effectiveness, biopharma focuses on qualification and portability to clinical pipelines, and CROs require broad reagent and equipment portfolios to service diverse client needs. Collectively, these segmentation perspectives underscore the importance of tailored value propositions, validated workflows, and service models that address the specific technical and commercial drivers inherent to each category.

Regional dynamics and competitive positioning across the Americas, Europe Middle East & Africa, and Asia-Pacific informing market entry and partnership strategies

Regional dynamics are shaping competitive positioning and go-to-market strategies across major geographies. In the Americas, investment in biopharmaceutical R&D, coupled with a strong presence of contract research organizations and advanced academic centers, drives demand for high-performance reagents and integrated instruments that support translational pipelines. Market participants in this region often prioritize regulatory alignment, vendor transparency, and partnership models that can accelerate clinical translation.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks and funding models vary widely, creating both opportunities and complexity. In these markets, suppliers benefit from localized validation data and collaborative partnerships with regional research consortia. Europe in particular emphasizes reproducibility and quality management systems, while several Middle Eastern and African centers are investing in capacity building and infrastructure modernization. Asia-Pacific is characterized by rapid expansion in life science R&D capability, government-led initiatives to support biotechnology, and a growing manufacturing base. Suppliers operating in Asia-Pacific are increasingly localizing production and offering scalable solutions that cater to a broad range of end users, from emerging academic centers to large domestic biopharma firms. Understanding these regional nuances is essential for prioritizing market entry tactics, distribution strategies, and localized service offerings.

Strategic profiles and capability analysis of leading companies shaping transfection reagents and equipment through R&D, partnerships, and platform expansion

Leading companies in the space are differentiating through a combination of R&D investment, strategic partnerships, and expanding platform capabilities. Some firms are concentrating on reagent chemistry optimization to enhance delivery efficiency and reduce cytotoxicity across challenging cell types, while others are integrating hardware, software, and consumables to deliver turnkey solutions that lower the barrier to adoption. Collaborations between reagent developers and instrument manufacturers are becoming more common, as are partnerships with academic labs and contract research organizations to validate workflows across diverse applications.

Corporate strategies also reflect an emphasis on regulatory readiness and quality systems that support translational use cases. Companies that proactively generate comprehensive validation data and provide robust technical support are establishing credibility with biopharmaceutical customers and CROs. Additionally, several firms are exploring modular business models, combining direct sales with channel partnerships and subscription services for consumables and software. These approaches enhance customer lifetime value and create recurring revenue streams while enabling more predictable supply and service delivery for critical R&D activities.

Actionable recommendations for industry leaders to accelerate adoption, optimize supply chains, and capture value across diverse transfection market segments

Industry leaders should adopt a set of pragmatic actions to accelerate adoption, strengthen supply chains, and capture strategic value across segments. First, invest in creating validated, cross-platform protocols and comprehensive application notes that demonstrate performance across the primary cell types and use cases. This evidence base reduces adoption friction and supports procurement decisions across academic, biopharma, and CRO customers. Second, diversify manufacturing and logistics footprints to mitigate trade and tariff risks while ensuring continuity of supply for critical reagents and instrument components.

Third, pursue strategic alliances with technology partners and end users to co-develop solutions tailored to high-value applications such as gene therapy and complex cell line development. Fourth, enhance commercial models by combining equipment sales with consumable subscriptions and managed services that provide predictable revenue and deeper customer engagement. Finally, strengthen technical service and training offerings to support reproducibility and to facilitate rapid scale-up from discovery to translational stages. Together, these actions will help suppliers align product development and go-to-market execution with evolving customer expectations and regulatory requirements.

Research methodology detailing data sources, stakeholder interviews, primary and secondary research integration, and analytical frameworks ensuring rigor

The research methodology underpinning this analysis integrates primary interviews, secondary data synthesis, and cross-validated expert review to ensure analytical rigor and relevance. Primary research included structured interviews with laboratory directors, procurement managers, R&D scientists, and commercial leaders across a representative set of academic institutions, biopharmaceutical companies, and contract research organizations. These conversations provided direct insight into procurement drivers, performance pain points, and validation priorities.

Secondary research involved a systematic review of peer-reviewed literature, regulatory guidance, patent filings, and technical white papers to contextualize technological trends and to verify product claims. Data triangulation was applied to reconcile divergent inputs and to surface consistent patterns across geographies and end-user types. Analytical frameworks used in the study include value chain mapping, supplier capability assessment, and scenario-based sensitivity analysis to explore the impacts of supply disruption and regulatory change. Throughout, subject matter experts provided iterative review to refine interpretations and to ensure that findings are actionable for decision-makers.

Conclusion synthesizing strategic implications, risk considerations, and priority actions for stakeholders navigating the transfection ecosystem

In conclusion, the transfection reagents and equipment ecosystem is advancing at the intersection of innovation, regulatory expectation, and shifting procurement behaviors. Technological progress in delivery chemistries, automation, and integration with gene editing platforms is expanding the range of tractable applications while raising the bar for reproducibility and quality assurance. At the same time, trade dynamics and evolving regional capabilities are reshaping supply chain strategies and commercial approaches.

Stakeholders should prioritize resilience, validated performance, and customer-centric service models to capture emerging opportunities. For product developers, the imperative is to align R&D investment with the specific needs of diverse cell types and application areas. For end users, building robust vendor qualification and inventory management practices will protect continuity of research. As the field evolves, coordinated partnerships among suppliers, customers, and regulatory bodies will be critical to translate technological potential into clinical and commercial outcomes. The synthesis offered here provides a strategic foundation for informed decision-making and targeted action in this dynamic sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of lipid nanoparticle formulations for mRNA vaccine delivery and gene editing applications
  • 5.2. Integration of automated high-throughput transfection platforms for large scale screening and research
  • 5.3. Development of nonviral vector optimization strategies to enhance safety and delivery efficiency in gene therapy
  • 5.4. Advances in electrotransfection device miniaturization for precise intracellular delivery with reduced cell damage
  • 5.5. Implementation of AI driven reagent formulation optimization to improve transfection efficiency and reproducibility
  • 5.6. Rise of GMP compliant transfection workflows to support clinical manufacturing of cell and gene therapies
  • 5.7. Engineering of peptide based delivery systems for targeted intracellular transport of therapeutic cargo molecules
  • 5.8. Expansion of dual delivery platforms enabling simultaneous transfection of DNA and RNA for complex cell modulation
  • 5.9. Emergence of sustainable manufacturing processes and green chemistry in reagent production to reduce environmental impact
  • 5.10. Adoption of microfluidic based transfection devices for single cell analysis and high precision gene delivery

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Transfection Reagents & Equipment Market, by Product Type

  • 8.1. Equipment
  • 8.2. Reagents

9. Transfection Reagents & Equipment Market, by Cell Type

  • 9.1. Bacterial Cells
  • 9.2. Insect Cells
  • 9.3. Mammalian Cells
  • 9.4. Plant Cells

10. Transfection Reagents & Equipment Market, by Application

  • 10.1. Cell Line Development
  • 10.2. Drug Discovery
  • 10.3. Gene Therapy Research

11. Transfection Reagents & Equipment Market, by End User

  • 11.1. Academic And Research Institutes
  • 11.2. Biopharmaceutical Companies
  • 11.3. Contract Research Organizations

12. Transfection Reagents & Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Transfection Reagents & Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Transfection Reagents & Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Agilent Technologies, Inc.
    • 15.3.2. Altogen Biosystems
    • 15.3.3. Applied Biological Materials, Inc.
    • 15.3.4. Bex Co.,ltd.
    • 15.3.5. BioVision Inc.
    • 15.3.6. Bio-Rad Laboratories, Inc.
    • 15.3.7. Cytiva
    • 15.3.8. GeneCopoeia, Inc.
    • 15.3.9. Qiagen N.V.
    • 15.3.10. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. TRANSFECTION REAGENTS & EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. TRANSFECTION REAGENTS & EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. TRANSFECTION REAGENTS & EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 89. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 91. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 93. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 95. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 114. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY TRANSFECTIO